239 related articles for article (PubMed ID: 12915445)
1. Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network.
Faucherre A; Desbois P; Satre V; Lunardi J; Dorseuil O; Gacon G
Hum Mol Genet; 2003 Oct; 12(19):2449-56. PubMed ID: 12915445
[TBL] [Abstract][Full Text] [Related]
2. Lowe syndrome protein Ocrl1 is translocated to membrane ruffles upon Rac GTPase activation: a new perspective on Lowe syndrome pathophysiology.
Faucherre A; Desbois P; Nagano F; Satre V; Lunardi J; Gacon G; Dorseuil O
Hum Mol Genet; 2005 Jun; 14(11):1441-8. PubMed ID: 15829501
[TBL] [Abstract][Full Text] [Related]
3. The effect of missense mutations in the RhoGAP-homology domain on ocrl1 function.
Lichter-Konecki U; Farber LW; Cronin JS; Suchy SF; Nussbaum RL
Mol Genet Metab; 2006; 89(1-2):121-8. PubMed ID: 16777452
[TBL] [Abstract][Full Text] [Related]
4. Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network.
Choudhury R; Diao A; Zhang F; Eisenberg E; Saint-Pol A; Williams C; Konstantakopoulos A; Lucocq J; Johannes L; Rabouille C; Greene LE; Lowe M
Mol Biol Cell; 2005 Aug; 16(8):3467-79. PubMed ID: 15917292
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of the Lowe syndrome protein OCRL1.
Lowe M
Traffic; 2005 Sep; 6(9):711-9. PubMed ID: 16101675
[TBL] [Abstract][Full Text] [Related]
6. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.
Jänne PA; Suchy SF; Bernard D; MacDonald M; Crawley J; Grinberg A; Wynshaw-Boris A; Westphal H; Nussbaum RL
J Clin Invest; 1998 May; 101(10):2042-53. PubMed ID: 9593760
[TBL] [Abstract][Full Text] [Related]
7. A novel OCRL1 mutation in a patient with the mild phenotype of Lowe syndrome.
Sugimoto K; Nishi H; Miyazawa T; Fujita S; Okada M; Takemura T
Tohoku J Exp Med; 2014 Mar; 232(3):163-6. PubMed ID: 24614960
[TBL] [Abstract][Full Text] [Related]
8. Ocrl1, a PtdIns(4,5)P(2) 5-phosphatase, is localized to the trans-Golgi network of fibroblasts and epithelial cells.
Dressman MA; Olivos-Glander IM; Nussbaum RL; Suchy SF
J Histochem Cytochem; 2000 Feb; 48(2):179-90. PubMed ID: 10639484
[TBL] [Abstract][Full Text] [Related]
9. Role of Ocrl1 in primary cilia assembly.
Madhivanan K; Ramadesikan S; Aguilar RC
Int Rev Cell Mol Biol; 2015; 317():331-47. PubMed ID: 26008789
[TBL] [Abstract][Full Text] [Related]
10. OCRL1 engages with the F-BAR protein pacsin 2 to promote biogenesis of membrane-trafficking intermediates.
Billcliff PG; Noakes CJ; Mehta ZB; Yan G; Mak L; Woscholski R; Lowe M
Mol Biol Cell; 2016 Jan; 27(1):90-107. PubMed ID: 26510499
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the Rab binding domain of OCRL1 in complex with Rab8 and functional implications of the OCRL1/Rab8 module for Lowe syndrome.
Hagemann N; Hou X; Goody RS; Itzen A; Erdmann KS
Small GTPases; 2012; 3(2):107-10. PubMed ID: 22790198
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome.
Lin T; Orrison BM; Leahey AM; Suchy SF; Bernard DJ; Lewis RA; Nussbaum RL
Am J Hum Genet; 1997 Jun; 60(6):1384-8. PubMed ID: 9199559
[TBL] [Abstract][Full Text] [Related]
13. Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase.
Coon BG; Mukherjee D; Hanna CB; Riese DJ; Lowe M; Aguilar RC
Hum Mol Genet; 2009 Dec; 18(23):4478-91. PubMed ID: 19700499
[TBL] [Abstract][Full Text] [Related]
14. Identification of OCRL1 mutations in two Taiwanese Lowe syndrome patients.
Chou YY; Chao SC; Chiou YY; Lin SJ
Acta Paediatr Taiwan; 2005; 46(4):226-9. PubMed ID: 16381338
[TBL] [Abstract][Full Text] [Related]
15. Oculocerebrorenal syndrome of Lowe (OCRL) controls leukemic T-cell survival by preventing excessive PI(4,5)P
Chen H; Lu C; Tan Y; Weber-Boyvat M; Zheng J; Xu M; Xiao J; Liu S; Tang Z; Lai C; Li M; Olkkonen VM; Yan D; Zhong W
J Biol Chem; 2023 Jun; 299(6):104812. PubMed ID: 37172724
[TBL] [Abstract][Full Text] [Related]
16. A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1.
Hou X; Hagemann N; Schoebel S; Blankenfeldt W; Goody RS; Erdmann KS; Itzen A
EMBO J; 2011 Apr; 30(8):1659-70. PubMed ID: 21378754
[TBL] [Abstract][Full Text] [Related]
17. Carrier assessment in families with lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination.
Röschinger W; Muntau AC; Rudolph G; Roscher AA; Kammerer S
Mol Genet Metab; 2000 Mar; 69(3):213-22. PubMed ID: 10767176
[TBL] [Abstract][Full Text] [Related]
18. Coordination of Rho and Rac GTPase function via p190B RhoGAP.
Bustos RI; Forget MA; Settleman JE; Hansen SH
Curr Biol; 2008 Oct; 18(20):1606-11. PubMed ID: 18948007
[TBL] [Abstract][Full Text] [Related]
19. Ocular Pathology of Oculocerebrorenal Syndrome of Lowe: Novel Mutations and Genotype-Phenotype Analysis.
Song E; Luo N; Alvarado JA; Lim M; Walnuss C; Neely D; Spandau D; Ghaffarieh A; Sun Y
Sci Rep; 2017 May; 7(1):1442. PubMed ID: 28473699
[TBL] [Abstract][Full Text] [Related]
20. Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
Egot M; Lasne D; Poirault-Chassac S; Mirault T; Pidard D; Dreano E; Elie C; Gandrille S; Marchelli A; Baruch D; Rendu J; Fauré J; Flaujac C; Gratacap MP; Sié P; Gaussem P; Salomon R; Baujat G; Bachelot-Loza C
Br J Haematol; 2021 Mar; 192(5):909-921. PubMed ID: 33528045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
